Brought to you by 
Reliant licenses US rights to Pronova Biocare's Omacor
10 May 2022
Executive Summary
Reliant Pharmaceuticals (sells therapeutics in primary care and specialty markets) received exclusive rights from Pronova Biocare AS (develops omega-3 fatty acid) to market and distribute Omacor (omega-3 acid ethyl esters) in the US.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Reliant licenses US rights to Pronova Biocare's Omacor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice